Document is current
Any future updates will be listed below
-
Authors
Lin, Ruoxuan
Chen, Yijie
Wang, Yaoqin
Tang, Lina
Huang, Weiqin
-
Funding
Funding for this research was provided by:
Startup Fund for Scientific Research of Fujian Medical University (No.2022QH1162)
Joint Funds for the Innovation of Science and Technology, Fujian Province (No.2020Y9037)
- License Information
-
More Information
Article History
Received: 2 August 2025
Accepted: 22 October 2025
First Online: 18 November 2025
Declarations
:
: This study was approved by the Ethics Review Committee of Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital (approval number K2023-109-01), while an informed consent was obtained from all individual participants. The study was conducted in accordance with the Declaration of Helsinki. All methods were performed in accordance with the relevant guidelines and regulations of the National Health Commission of the People’s Republic of China.
: Not applicable.
: The authors declare no competing interests.
